Detalhe da pesquisa
1.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
2.
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.
Future Oncol
; 19(1): 61-75, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656302
3.
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Oncologist
; 26(1): 7-16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852072
4.
Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer.
J Oncol Pharm Pract
; 27(6): 1371-1381, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847480
5.
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
Cancer
; 126(2): 373-380, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769875
6.
Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults.
Breast Cancer Res Treat
; 179(2): 471-477, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630293
7.
Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing.
Genet Med
; 22(11): 1892-1897, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624572
8.
Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis.
Invest New Drugs
; 38(5): 1601-1604, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907737
9.
Assessing the psychosocial needs of newly diagnosed patients with nonsmall cell lung cancer: Identifying factors associated with distress.
Psychooncology
; 28(4): 815-821, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758101
10.
Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists.
Hum Resour Health
; 15(1): 42, 2017 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28655303
11.
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.
Lancet Oncol
; 17(5): 577-89, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27083334
12.
Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.
Oncologist
; 19(6): 623-30, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24807916
13.
Evaluation of E-cadherin, ß-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.
Clin Invest Med
; 37(5): E320-30, 2014 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25282138
14.
Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial.
Lung Cancer
; 190: 107529, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452600
15.
The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing-Patient's Willingness-to-Pay: A Brief Report.
JTO Clin Res Rep
; 5(1): 100615, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38292413
16.
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors.
Curr Oncol
; 31(4): 1865-1875, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668043
17.
Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.
Nat Commun
; 15(1): 4165, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755180
18.
The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration System.
Stud Health Technol Inform
; 183: 98-103, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23388263
19.
Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer.
Curr Oncol
; 30(8): 7099-7111, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622996
20.
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression.
Curr Oncol
; 30(8): 7499-7507, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623024